Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28619af0a5061be1a1ac3c90a385564b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-0052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-0054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-0063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00791 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00797 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-0087 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00291 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00452 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-0225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00464 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-0239 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3673 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3606 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F7-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F7-0085 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00 |
filingDate |
2019-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_489d9bcbc02ab343a5a2cc21eb6c912e |
publicationDate |
2020-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020069458-A1 |
titleOfInvention |
Compositions, treatment systems, and methods for fractionally freezing tissue |
abstract |
Compositions and formulations having one or more anti-freeze proteins for use with devices and systems that enable tissue cooling, such as cryotherapy applications, for alteration and reduction of adipose tissue are described. Embodiments of the technology are further directed to methods, compositions having one or more anti-freeze proteins and devices that protect non-targeted cells from freeze damage during dermatological and related aesthetic procedures requiring sustained exposure to cold temperatures. Further embodiments of the technology include systems for enhancing sustained and/or replenishing release of a freezing point depressant having one or more anti-freeze proteins to a treatment site prior to and during cooling applications. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022022159-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113827545-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446175-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11395925-B2 |
priorityDate |
2018-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |